BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25754666)

  • 21. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.
    Silva-Dias A; Miranda IM; Branco J; Monteiro-Soares M; Pina-Vaz C; Rodrigues AG
    Front Microbiol; 2015; 6():205. PubMed ID: 25814989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptococcus oralis and Candida albicans Synergistically Activate μ-Calpain to Degrade E-cadherin From Oral Epithelial Junctions.
    Xu H; Sobue T; Bertolini M; Thompson A; Dongari-Bagtzoglou A
    J Infect Dis; 2016 Sep; 214(6):925-34. PubMed ID: 27190184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Filament condition-specific response elements control the expression of NRG1 and UME6, key transcriptional regulators of morphology and virulence in Candida albicans.
    Childers DS; Kadosh D
    PLoS One; 2015; 10(3):e0122775. PubMed ID: 25811669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host response to Candida albicans bloodstream infection and sepsis.
    Duggan S; Leonhardt I; Hünniger K; Kurzai O
    Virulence; 2015; 6(4):316-26. PubMed ID: 25785541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Essential Oils and Bioactive Fractions on Streptococcus mutans and Candida albicans Biofilms: A Confocal Analysis.
    Freires IA; Bueno-Silva B; Galvão LC; Duarte MC; Sartoratto A; Figueira GM; de Alencar SM; Rosalen PL
    Evid Based Complement Alternat Med; 2015; 2015():871316. PubMed ID: 25821503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Of mice, flies--and men? Comparing fungal infection models for large-scale screening efforts.
    Brunke S; Quintin J; Kasper L; Jacobsen ID; Richter ME; Hiller E; Schwarzmüller T; d'Enfert C; Kuchler K; Rupp S; Hube B; Ferrandon D
    Dis Model Mech; 2015 May; 8(5):473-86. PubMed ID: 25786415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidiasis (vulvovaginal).
    Martin Lopez JE
    BMJ Clin Evid; 2015 Mar; 2015():. PubMed ID: 25775428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.
    Kumar R; Saraswat D; Tati S; Edgerton M
    Infect Immun; 2015 Jul; 83(7):2614-26. PubMed ID: 25870228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall.
    Hall RA
    Mol Microbiol; 2015 Jul; 97(1):7-17. PubMed ID: 25846717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida survival strategies.
    Polke M; Hube B; Jacobsen ID
    Adv Appl Microbiol; 2015; 91():139-235. PubMed ID: 25911234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New signaling pathways govern the host response to C. albicans infection in various niches.
    Liu Y; Shetty AC; Schwartz JA; Bradford LL; Xu W; Phan QT; Kumari P; Mahurkar A; Mitchell AP; Ravel J; Fraser CM; Filler SG; Bruno VM
    Genome Res; 2015 May; 25(5):679-89. PubMed ID: 25858952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interkingdom networking within the oral microbiome.
    Nobbs AH; Jenkinson HF
    Microbes Infect; 2015 Jul; 17(7):484-92. PubMed ID: 25805401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of Novel Synthetic Peptides against Candida albicans.
    Lum KY; Tay ST; Le CF; Lee VS; Sabri NH; Velayuthan RD; Hassan H; Sekaran SD
    Sci Rep; 2015 May; 5():9657. PubMed ID: 25965506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence of Candida sp. to host tissues and cells as one of its pathogenicity features.
    Modrzewska B; Kurnatowski P
    Ann Parasitol; 2015; 61(1):3-9. PubMed ID: 25911031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections--a prospective study from a tertiary care hospital.
    Kaur M; Gupta V; Gombar S; Chander J; Sahoo T
    Indian J Med Microbiol; 2015; 33(2):248-54. PubMed ID: 25865976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growing Candida albicans Biofilms on Paper Support and Dynamic Conditions.
    Selow ML; Rymovicz AU; Ribas CR; Saad RS; Rosa RT; Rosa EA
    Mycopathologia; 2015 Aug; 180(1-2):27-33. PubMed ID: 25855360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pseudomonas Quinolone Signal Inhibits Biofilm Development of Streptococcus mutans.
    Inaba T; Oura H; Morinaga K; Toyofuku M; Nomura N
    Microbes Environ; 2015; 30(2):189-91. PubMed ID: 25854411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofilm formation and genetic variability of BCR1 gene in the Candida parapsilosis complex.
    Treviño-Rangel Rde J; Rodríguez-Sánchez IP; Rosas-Taraco AG; Hernández-Bello R; González JG; González GM
    Rev Iberoam Micol; 2015; 32(3):180-4. PubMed ID: 25843001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.